What is the current Price Target for the Biotest stock?

The average Biotest target price is €37.20. This is -10.58% lower than the current stock price. 1 Analyst has issued a Biotest price target 2025.

How high will the Biotest stock rise?

No reliable answer can be given as to how high the Biotest stock will rise. The performance of stocks, including the Biotest stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Biotest stock today?

The performance of Biotest stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Biotest stock fall?

The decline in Biotest stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Biotest Forecast, price target & analysts

€41.60

0.00% day before yesterday

Xetra, Nov 01, 05:36 pm CET

ISIN

DE0005227201

Symbol

BIO

Index

CDAX

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts Strategies

Biotest Target price 2024 - Analyst rating & recommendation

Biotest Classifications & Recommendation:

Hold

100%

Biotest Price Target

Target Price	€37.20
Price	€41.60
Deviation	10.58% register free of charge
Number of Estimates	1

	1 Analyst has issued a Biotest price target 2025. The average Biotest target price is €37.20. This is 10.58% register free of charge lower than the current stock price.
	A rating was issued by 1 analysts: 0 Analysts recommend Biotest to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Biotest stock has an average upside potential 2025 of 10.58% register free of charge . Most analysts recommend the Biotest stock at Hold.

Discover more stocks with a high price target

Valneva 206.16%

CureVac N.V. 152.80%

Plug Power Inc. 89.59%

Bavarian Nordic 46.30%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now

The Apple stock at a glance with charts, current key metrics, news and stock analyses.

The Best Dividend Stocks in the Dividend Top Scorer list.

Stock Analyses of the Best Stocks Worldwide.

Start building wealth today